A Brand New Network
for Allogeneic Cell
Therapy Success

Welcome to the Allogeneic Cell Therapy: Searchlight network

Built by the cell therapy community for the cell therapy community

Membership allows strategic leaders to plug into a ready-made allo-specific network of peers to work with in a facilitated, structured but boundaryless way throughout the year to access vital new thinking, identify critical short cuts and avoid costly mistakes, providing vital insights into allogeneic next practice before it becomes best practice and to help overcome shared capacity, durability, efficacy and regulatory challenges.

Don’t miss out on the opportunity to be part of these critical conversations 

"Effectively scaling up the manufacturing of allogeneic drug products"

"Enhancing cell potency without increasing toxicity"

"Creating durable and persistent allogeneic therapies"

Join your peers today and be part of a global community of like-minded individuals 

Searchlight - LEAP HR - Exec Summary lock up (15)

Membership brochure

For more information on what’s included as part of the Allogeneic Cell Therapy: Searchlight membership, please download the membership brochure. 

Here’s what you’ll learn more about: 

  • The unique mission and purpose of the network 
  • What membership includes 
  • How the quarterly cornerstone meetings work 
  • How bespoke value delivery works 
  • How we deliver demonstrable value to you 
  • Annual member investment 

The feedback from members speaks for itself…

Oliver Kraemer, Head of Gene Edited Platforms, BMS

“This is such a fast moving field and we’re all learning together. Every new paper published and every new clinical trial adds more to the picture. There is huge benefit of strategic exchange in sharing what’s working and what’s not”

Iulia Diaconu, VP Immunotherapy, ElevateBio

"Searchlight: Allogeneic Cell Therapy offers connections and insights that aren't possible to access anywhere else, and gives us the opportunity to collaborate and build partnerships to help us all move forward in ways we wouldn’t otherwise have been able to."

Carlos Yuraszeck, Executive Director of GMP Operations, Astellas

"It's possible in our industry to become very isolated and insular, but what's clear to me is that we can’t really do this on our own as effectively as if we work together: it’s way too complicated, there are too many moving parts. For the good of the community, the industry and our patients, we should be actively looking for opportunities to learn from each other, and this is a perfect chance to do just that."

For more reviews about Allogeneic Cell Therapy: Searchlight membership, head to our testimonials page. and hear directly from our members about why they've joined.

Discover how we can provide you with demonstrable value…

Save time and money

Access timely insights to allow faster access to the clinic and increase your chances of success once you get there

Make valuable connections

Plug into a collaborative network sharing the full range of non-competitive ways to overcome common challenges

Amplify the allo network

Whitepaper outputs will amplify member positions to an audiences of regulators, suppliers, partners and more

Who qualifies for Searchlight: Allogeneic Cell Therapy?


Strategic allo leaders 

Motivated to share


In sight of the clinic 


Member companies are represented by one internal champion who has strategic oversight over its allogeneic program

Members will require a collaborative mindset, focused on what can be shared rather than being defined by what can’t

Members will be curated based on development stage (with those either in or close to reaching the clinic having priority)